Jason Gardner
Overview
Jason Gardner received an average of $2M in total compensation, including $440K in salary, at Dianthus Therapeutics from 2017 to 2023. Jason Gardner also received an average of $113M at Marqeta between 2020 and 2021.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
Dianthus TherapeuticsFormer President and Chief Executive Officer
Dianthus TherapeuticsFormer President and Chief Executive Officer
MarqetaChief Executive Officer
Dianthus TherapeuticsPresident and Chief Executive Officer
MarqetaChief Executive Officer
Dianthus TherapeuticsPresident and Chief Executive Officer
Dianthus TherapeuticsPresident and Chief Executive Officer
Dianthus TherapeuticsPresident and Chief Executive Officer
Dianthus TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 11, 2024, April 25, 2022, May 2, 2022, April 21, 2021, and April 25, 2019.
Related executives
We found 12 more executives who work or worked at Dianthus Therapeutics and Marqeta.
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
Lisa Olson
Dianthus Therapeutics
Chief Scientific Officer
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
Simrat Randhawa
Dianthus Therapeutics
Chief Medical Officer
Ryan Savitz
Dianthus Therapeutics
Chief Financial Officer
Randy Kern
Marqeta
Chief Technology Officer
Tripp Faix
Marqeta
Chief Financial Officer
News
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Dianthus Therapeutics CEO Jason Gardner's 2021 pay falls 28% to $2.2M
May 2, 2022
Marqeta CEO Jason Gardner's 2021 pay jumps 7,132% to $224M
April 25, 2022
Dianthus Therapeutics CEO Jason Gardner's 2020 pay jumps 88% to $3.1M
April 21, 2021
Dianthus Therapeutics CEO Jason Gardner's 2018 pay jumps 692% to $4.7M
April 25, 2019